99 related articles for article (PubMed ID: 8001682)
1. Susceptibility of phospholipids of oxidizing LDL to enzymatic hydrolysis modulates uptake by P388D1 macrophage-like cells.
Fyrnys B; Blencowe C; Deigner HP
FEBS Lett; 1995 Jan; 357(1):7-12. PubMed ID: 8001682
[TBL] [Abstract][Full Text] [Related]
2. Implication of lipoprotein associated phospholipase A2 activity in oxLDL uptake by macrophages.
Markakis KP; Koropouli MK; Grammenou-Savvoglou S; van Winden EC; Dimitriou AA; Demopoulos CA; Tselepis AD; Kotsifaki EE
J Lipid Res; 2010 Aug; 51(8):2191-201. PubMed ID: 20332422
[TBL] [Abstract][Full Text] [Related]
3. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL.
Tsoukatos DC; Arborati M; Liapikos T; Clay KL; Murphy RC; Chapman MJ; Ninio E
Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3505-12. PubMed ID: 9437199
[TBL] [Abstract][Full Text] [Related]
4. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.
Watson AD; Navab M; Hama SY; Sevanian A; Prescott SM; Stafforini DM; McIntyre TM; Du BN; Fogelman AM; Berliner JA
J Clin Invest; 1995 Feb; 95(2):774-82. PubMed ID: 7860760
[TBL] [Abstract][Full Text] [Related]
5. LDL-associated phospholipase A does not protect LDL against lipid peroxidation in vitro.
Schnitzer E; Pinchuk I; Fainaru M; Lichtenberg D; Yedgar S
Free Radic Biol Med; 1998 May; 24(7-8):1294-303. PubMed ID: 9626586
[TBL] [Abstract][Full Text] [Related]
6. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma.
Stremler KE; Stafforini DM; Prescott SM; Zimmerman GA; McIntyre TM
J Biol Chem; 1989 Apr; 264(10):5331-4. PubMed ID: 2494162
[TBL] [Abstract][Full Text] [Related]
7. Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2.
Kramer RM; Jakubowski JA; Deykin D
Biochim Biophys Acta; 1988 Apr; 959(3):269-79. PubMed ID: 3355850
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated.
Liapikos TA; Antonopoulou S; Karabina SP; Tsoukatos DC; Demopoulos CA; Tselepis AD
Biochim Biophys Acta; 1994 Jun; 1212(3):353-60. PubMed ID: 8199206
[TBL] [Abstract][Full Text] [Related]
9. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.
Steinbrecher UP; Pritchard PH
J Lipid Res; 1989 Mar; 30(3):305-15. PubMed ID: 2723538
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E
Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095
[TBL] [Abstract][Full Text] [Related]
11. PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation.
Dentan C; Lesnik P; Chapman MJ; Ninio E
Arterioscler Thromb; 1994 Mar; 14(3):353-60. PubMed ID: 8123638
[TBL] [Abstract][Full Text] [Related]
12. Phospholipase A(2) activity in non-glycated and glycated low density lipoproteins.
Sakurai T; Yamamoto Y; Baba N; Nakano M
Biochim Biophys Acta; 1996 May; 1301(1-2):85-9. PubMed ID: 8652655
[TBL] [Abstract][Full Text] [Related]
13. Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidation.
Androulakis N; Durand H; Ninio E; Tsoukatos DC
J Lipid Res; 2005 Sep; 46(9):1923-32. PubMed ID: 15995176
[TBL] [Abstract][Full Text] [Related]
14. Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma.
Subramanian VS; Goyal J; Miwa M; Sugatami J; Akiyama M; Liu M; Subbaiah PV
Biochim Biophys Acta; 1999 Jul; 1439(1):95-109. PubMed ID: 10395969
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of platelet-activating factor acetylhydrolase from peritoneal fluid obtained from guinea pigs after endotoxin shock.
Karasawa K; Yato M; Setaka M; Nojima S
J Biochem; 1994 Aug; 116(2):374-9. PubMed ID: 7822257
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines.
Marathe GK; Davies SS; Harrison KA; Silva AR; Murphy RC; Castro-Faria-Neto H; Prescott SM; Zimmerman GA; McIntyre TM
J Biol Chem; 1999 Oct; 274(40):28395-404. PubMed ID: 10497200
[TBL] [Abstract][Full Text] [Related]
17. The platelet-activating factor acetylhydrolase from human erythrocytes. Purification and properties.
Stafforini DM; Rollins EN; Prescott SM; McIntyre TM
J Biol Chem; 1993 Feb; 268(6):3857-65. PubMed ID: 8440681
[TBL] [Abstract][Full Text] [Related]
18. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.
McCall MR; La Belle M; Forte TM; Krauss RM; Takanami Y; Tribble DL
Biochim Biophys Acta; 1999 Jan; 1437(1):23-36. PubMed ID: 9931415
[TBL] [Abstract][Full Text] [Related]
19. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages.
Herrmann DB; Ferber E; Munder PG
Biochim Biophys Acta; 1986 Mar; 876(1):28-35. PubMed ID: 3947667
[TBL] [Abstract][Full Text] [Related]
20. Identification of a membrane-associated 1-0-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine hydrolyzing phospholipase A2 in guinea pig 1 epidermis. Implications in the cutaneous biosynthesis of platelet-activating factor.
Wong B; Tang W; Ziboh VA
FEBS Lett; 1992 Jul; 305(3):213-6. PubMed ID: 1299618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
